跳至主要内容
临床试验/NL-OMON53453
NL-OMON53453招募中不适用

Filgotinib in the treatment of patients with ulcerative colitis: towards precision medicine (TOPS study) - TOPS

niversitair Medisch Centrum Utrecht0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Previously (>=3 months) documented diagnosis of ulcerative colitis
  • - Moderately to severe ulcerative colitis, defined as a Mayo score of 6-12.
  • - Age >= 18 years
  • - Indication for the start of filgotinib, as determined by the treating
  • physician(s)

排除标准

  • - No informed consent has been obtained
  • - The patient is diagnosed with Crohn*s disease
  • - The concomitant use of biological medication
  • - Previous failure of a JAK-inhibitor
  • - Recent (<4 weeks) start or intensification of other topical or systemic
  • treatments for UC
  • - Immunodeficiency (e.g. HIV, SCID)
  • - Acute severe ulcerative colitis
  • - Pregnancy or lactating female

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验